Mignar (Miglitol) 50 mg Tablets are an oral anti-diabetic medication used to manage type 2 diabetes mellitus, particularly in patients who struggle with controlling post-meal blood sugar levels. Miglitol is an alpha-glucosidase inhibitor, which delays the breakdown and absorption of carbohydrates in the small intestine, thereby reducing the postprandial glucose spike after meals. It is often prescribed alongside diet, exercise, or other anti-diabetic agents like metformin or sulfonylureas.

• Controls postprandial (after-meal) blood sugar spikes

• Complements other anti-diabetic medications

• Helps maintain stable glucose levels throughout the day

• Reduces the risk of long-term complications of diabetes

• Does not typically cause hypoglycemia when used alone

• Take orally just before the first bite of each main meal

• Swallow the tablet whole with water

• Follow dietary and lifestyle recommendations provided by your healthcare provider

• Use regularly at the same times each day for best results

• Typical starting dose: 50 mg three times daily before meals

• Dose may be adjusted by your physician based on blood glucose monitoring and response

• Should not be taken if a meal is skipped

• Always adhere to your doctor’s prescribed dose and schedule

• Not recommended for patients with inflammatory bowel disease, intestinal obstruction, or chronic intestinal disorders

• Use with caution in individuals with kidney impairment

• Should not be used in type 1 diabetes or diabetic ketoacidosis

• Regular monitoring of blood sugar levels is advised

• Avoid sugary foods if hypoglycemia occurs while on combination therapy

• Common side effects:

• Abdominal discomfort

• Bloating

• Less common but serious effects:

• Elevated liver enzymes (rare)

• Allergic skin reactions

•  

• Flatulence

• Diarrhea